Celon Laboratories Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2001.
2001 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Celon Laboratories Private Limited

Celon Laboratories Private Limited, a active private limited company, was established on 23 January 2001 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2001PTC036097. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹233.10 Cr and a paid-up capital of ₹65.10 Cr.

Formerly known as Medvin Labs Private Limited, Galen Labs Private Limited. It upholds a compliant status. Employing 535 professional, Its leadership includes Ravi Kumar Upputhalla (Company Secretary), Ajay Bhatia (Managing Director). Past directors included Sandeep Singhal, Akshya Kumar Mahapatra, Nagesh Kumar Middey. It holds ₹46.00 Cr open charges and ₹701.32 Cr settled loans. Its latest AGM occurred on 28 November 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.2, Aleap Industrial Estate Gajularamaram, Hyderabad, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2001PTC036097

  • Registration Number

    036097

  • Incorporation Date

    23 January 2001

  • Authorized Capital

    ₹233.10 Cr

  • Paid-Up Capital

    ₹65.10 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 233.10 Cr
  • Paid Up Capital ₹ 65.10 Cr
  • Company Age 25 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 46.00 Cr
  • Satisfied Charges ₹ 701.32 Cr
  • Revenue Growth **** -54.48%
  • Profit Growth **** -192.22%
  • Ebitda **** -163.62%
  • Net Worth -32.10%
  • Total Assets -13.78%
Company report

Celon Laboratories Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Celon Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Celon Laboratories Private Limited?
Current Directors
Name Designation Appointment Date Status
Ravi Kumar Upputhalla Company Secretary 02 Apr 2025 Current
Ajay Bhatia Managing Director 02 May 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee Director 23 Dec 2011 Past
Pramod Abcsdd Managing Director 15 Feb 2024 Past
Pramod Abcsdd Managing Director 15 Sep 2022 Past
Pramod Abcsdd Whole-Time Director 31 Oct 2018 Past
Pramod Abcsdd Director 15 Feb 2011 Past
Pramod Abcsdd Director 13 Nov 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Celon Laboratories.

Celon Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 54.48% decrease. The company also saw a substantial fall in profitability, with a 192.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 32.1%.

Celon Laboratories revenue growth over time
Celon Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -54.48%
*******
*******
*******
*******
Revenue from Operations
*******
 -54.68%
*******
*******
*******
*******
Total Assets
*******
 -13.78%
*******
*******
*******
*******
Profit or Loss
*******
 -192.22%
*******
*******
*******
*******
Net Worth
*******
 -32.10%
*******
*******
*******
*******
EBITDA
*******
 -163.62%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Celon Laboratories?

In 2023, Celon Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹460,000,000.00

Satisfied Charges

₹7,013,242,000.00

Charges Breakdown by Lending Institutions
  • Others : 46.00 Cr
Latest Charge Details
Date Lender Amount Status
21 Feb 2024 Others ₹46.00 Cr Open
06 Jul 2017 Others ₹500.00 Cr Satisfied
27 Feb 2015 Export Import Bank Of India ₹119.00 Cr Satisfied
25 Jun 2012 Kotak Mahindra Bank Limited ₹3.65 Cr Satisfied
27 Dec 2011 Icici Bank Limited ₹18.20 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Celon Laboratories?

Celon Laboratories has a workforce of 535 employees as of Nov 15, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Celon Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Celon Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Celon Laboratories
Recent Activity within the Organization
  • Annual General Meeting

    Celon Laboratories Private Limited last Annual general meeting of members was held on 28 Nov 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Rashmi Agarwal was appointed as a Company Secretary was appointed as a Company Secretary on 04 Aug 2025 & has been associated with this company since 9 months 29 days . was recorded as a recent event.

  • Director Appointment

    Progress on Ravi Kumar Upputhalla was appointed as a Company Secretary was appointed as a Company Secretary on 02 Apr 2025 & has been associated with this company since 1 year 2 months . was documented.

  • Balance Sheet

    The activity Celon Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Charges

    The activity A charge with Others of Rs. 46.00 Cr registered on 21 Feb 2024 with Charge ID 100877187 was modified on 06 Sep 2024. was completed.

  • Director Appointment

    The activity Ajay Bhatia was appointed as a Managing Director was appointed as a Managing Director on 02 May 2024 & has been associated with this company since 2 years 1 month . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Celon Laboratories Private Limited?

The CIN of Celon Laboratories Private Limited is U24232TG2001PTC036097.

Where is Celon Laboratories Private Limited headquartered?

Celon Laboratories Private Limited is headquartered at Plot No.2, Aleap Industrial Estate Gajularamaram, Hyderabad, Telangana, 500072.

When was Celon Laboratories Private Limited incorporated?

Celon Laboratories Private Limited was incorporated on 23 January 2001.

Who are the current directors of Celon Laboratories Private Limited?

The current directors of Celon Laboratories Private Limited are

What is the primary industry of Celon Laboratories Private Limited?

The primary industry of Celon Laboratories Private Limited is Manufacturing.

Is Celon Laboratories Private Limited a listed company?

Celon Laboratories Private Limited is unlisted.

What is the capital structure of Celon Laboratories Private Limited?

The authorized capital of Celon Laboratories Private Limited is ₹233.10 Cr, and the paid-up capital is ₹65.10 Cr.

What is the compliance status of Celon Laboratories Private Limited?

The compliance status of Celon Laboratories Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available